Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Banu Arun

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Journal of Global Oncology|September 11, 2018
Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast CancerOmalkhair Abulkhair, Mohammed Al Balwi, Ola Makram, et al.
Journal of Cancer Research and Clinical Oncology|June 27, 2008
Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or youngerYesim Eralp, Terry L Smith, Kadri Altundağ, et al.
NPJ Breast Cancer|April 8, 2022
Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancerHaven R Garber, Akshara Singareeka Raghavendra, Michael Lehner, et al.
Breast Cancer Research and Treatment|February 23, 2018
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutationsKatherine Clifton, Angelica Gutierrez-Barrera, Junsheng Ma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast CancerCarlos H Barcenas, Maryam N Shafaee, Arup K Sinha, et al.
Breast Cancer Research and Treatment|January 25, 2012
Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPROSwati Biswas, Neelam Tankhiwale, Amanda Blackford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancerEdgardo Rivera, Vicente Valero, Banu Arun, et al.
Autophagy|April 22, 2008
Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cellsUgur Akar, Arturo Chaves-Reyez, Magaly Barria, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 23, 2020
Patient characteristics associated with sleep disturbance in breast cancer survivorsChelsea G Ratcliff, Stephanie G Zepeda, Martica H Hall, et al.
Human Pathology|May 18, 2012
Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testingJeannine de la Cruz, Fabrice Andre, Robyn K Harrell, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Journal of Global Oncology|September 11, 2018
Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast CancerOmalkhair Abulkhair, Mohammed Al Balwi, Ola Makram, et al.
Journal of Cancer Research and Clinical Oncology|June 27, 2008
Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or youngerYesim Eralp, Terry L Smith, Kadri Altundağ, et al.
NPJ Breast Cancer|April 8, 2022
Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancerHaven R Garber, Akshara Singareeka Raghavendra, Michael Lehner, et al.
Breast Cancer Research and Treatment|February 23, 2018
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutationsKatherine Clifton, Angelica Gutierrez-Barrera, Junsheng Ma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast CancerCarlos H Barcenas, Maryam N Shafaee, Arup K Sinha, et al.
Breast Cancer Research and Treatment|January 25, 2012
Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPROSwati Biswas, Neelam Tankhiwale, Amanda Blackford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancerEdgardo Rivera, Vicente Valero, Banu Arun, et al.
Autophagy|April 22, 2008
Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cellsUgur Akar, Arturo Chaves-Reyez, Magaly Barria, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 23, 2020
Patient characteristics associated with sleep disturbance in breast cancer survivorsChelsea G Ratcliff, Stephanie G Zepeda, Martica H Hall, et al.
Human Pathology|May 18, 2012
Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testingJeannine de la Cruz, Fabrice Andre, Robyn K Harrell, et al.
Pageof 18